Quick answer
Semaglutide (C187H291N45O59, about 4.1 kDa) is verified by two complementary checks: HPLC for purity and mass spectrometry for identity, tied to a lot-specific COA.
- Purity: reversed-phase HPLC peak area; the product page lists ≥98%
- Identity: mass spectrometry against the theoretical mass, including the fatty-acid side chain
- Molecule-specific risks: truncations, off-target acylation, oxidation, aggregates, TFA content
- Paperwork: match the lot number on the COA to the vial; see the COA page
- Research use: For laboratory research use only; not for human consumption.
For laboratory research use only; not for human consumption.
A vial labeled "semaglutide" is only as useful to a research program as the data showing what it contains. Purity testing and identity testing answer different questions, and a lipidated peptide of about 4.1 kDa has its own failure modes. This guide walks through the methods used on semaglutide, what each result means, which impurities are specific to this molecule, and how to match a certificate of analysis (COA) to the vial in your hands. Background on the compound is in the semaglutide research overview.
What makes semaglutide analytically distinctive
Semaglutide is a 31-residue analog of GLP-1(7-37) with three deliberate modifications. Position 8 carries aminoisobutyric acid (Aib) in place of alanine, which blunts cleavage by dipeptidyl peptidase-4. Position 34 is arginine in place of lysine, leaving a single lysine for conjugation. Lysine 26 is acylated with a C18 fatty diacid through a gamma-glutamate and two 8-amino-3,6-dioxaoctanoic acid (OEG) spacers; the fatty chain promotes albumin binding (Lau et al., 2015). The result is a molecule with the formula C187H291N45O59, matching the semaglutide product page, and an average mass near 4,113.6 Da.
Three consequences follow for testing. The non-natural Aib residue and the side-chain linker mean that synthesis is more complex than for an unmodified peptide. The lipid makes the molecule far more hydrophobic than GLP-1 itself, which shapes the HPLC method. And the number of plausible by-products, from missed couplings to acylation at the wrong site, is larger.
Purity: how much of the vial is semaglutide
High-performance liquid chromatography (HPLC), almost always reversed-phase, separates sample components by hydrophobicity under a controlled solvent gradient. The target appears as a defined peak, and the purity percentage is the area of that peak divided by the total integrated area. Research-grade semaglutide is commonly specified at 98% or higher, and the product page lists ≥98% by HPLC. Smaller peaks point to synthesis by-products, truncated sequences or degradation products that visual inspection of a powder could never reveal. The method is explained further in understanding HPLC purity.
What to check on the chromatogram itself:
- Column and gradient. A longer, shallower gradient resolves closely related impurities; a steep gradient can merge them into the main peak and inflate purity.
- Detection wavelength. 214 or 220 nm responds to the peptide bond and is the usual choice for purity; 280 nm reports only aromatic residues and under-represents impurities lacking them.
- Integration threshold. Peaks below a reporting threshold, often 0.1% or so, are excluded; the stated threshold should be on the report.
- Blank run. Peaks that also appear in a solvent blank are artifacts and should not count as impurities.
Identity: confirming it is semaglutide, not something similar
Purity alone does not confirm identity, because a chromatographically clean sample could still be a different peptide. Mass spectrometry measures the molecular mass and compares it with the theoretical value computed from the formula. A match within instrument tolerance confirms that the backbone, including the Aib substitution, and the fatty-acid side chain are both present with the right composition. Electrospray ionization typically gives multiply charged ions (for a 4.1 kDa peptide, commonly the 4+, 5+ and 6+ states), which software deconvolutes to the neutral mass. The relationship between the two methods is explained in HPLC vs. mass spectrometry.
Mass alone has limits. Isomers with the same mass, such as a peptide where the fatty chain is attached at a different amine, or sequence variants with swapped residues, are not distinguished by an intact-mass reading. Tandem MS fragmentation or a peptide-mapping analysis resolves these, but is rarely reported on a routine COA. Knowing that limit helps you read a COA honestly: a pass means correct composition and size, not full structural proof.
Impurities particular to semaglutide
| Impurity class | Origin | How it shows up |
|---|---|---|
| Truncated or deletion sequences | Incomplete coupling during solid-phase synthesis | Lower mass by one or more residues; earlier or later HPLC peaks |
| Missing or mis-sited side chain | Incomplete or off-target acylation | Mass lower by the linker-lipid mass, or identical mass with shifted retention |
| Oxidation | Exposure of susceptible residues such as histidine and tryptophan to oxidants | +16 Da species on MS |
| Deamidation and isomerization | Aging in solution, pH and temperature | About +1 Da; shoulders on the main peak |
| Dimers and aggregates | Concentration, pH, agitation, hydrophobic side chain | Early peak on size-exclusion HPLC; multiples of the monomer mass |
| Epimers (D-amino acids) | Racemization during coupling | Same mass, slightly different retention; needs a shallow gradient |
Beyond the main purity figure
A thorough analytical package also considers what remains from synthesis. Residual trifluoroacetic acid (TFA) from cleavage and preparative purification, residual solvents and counter-ion content can all affect behavior in solution even when the primary HPLC peak looks clean. Whether the peptide is supplied as a TFA or acetate salt influences solubility and the net peptide content: a vial may contain, say, 10 mg of lyophilized solid of which only part is peptide, with the rest as counter-ion and water. This is why a complete COA reports more than a single percentage and why the label mass and the peptide mass are not always identical. If concentration accuracy matters, ask whether the content was determined by amino-acid analysis or UV, or is simply the weighed mass.
Quick reference: which method answers which question
| Question | Method | Reported as |
|---|---|---|
| How much of the signal is the target? | Reversed-phase HPLC | Area-percent purity |
| Is it the right molecule? | Intact-mass MS | Observed vs. theoretical mass |
| Are aggregates present? | Size-exclusion HPLC | Monomer and high-molecular-weight percent |
| How much is peptide vs. salt and water? | Amino-acid analysis, UV or elemental methods | Net peptide content |
Tying results to the vial in hand
Peptide synthesis is a batch process, so results from one lot do not guarantee the next. A batch-specific COA links a particular set of HPLC and mass-spectrometry results to the exact lot number on a vial. Verify the following when a vial arrives:
- The lot number on the COA matches the vial label.
- The test date is plausible relative to the manufacture and ship date.
- The reported mass is stated alongside the theoretical mass.
- The chromatogram is attached or available on request.
- The vial size matches the product listing (10 mg for the semaglutide research vial).
See how to read a COA for what each field means. Independent verification through third-party testing adds assurance beyond a supplier's in-house results, and V8 batch documentation is organized on the COA page. The product page lists ≥98% HPLC purity; check the COA page for the current status of any specific lot.
Purity is not the same as stability
A COA documents the state of the material on its test date. Semaglutide in lyophilized form is stable when kept cold, dry and dark, while reconstituted solutions are more vulnerable to aggregation, oxidation and adsorption to surfaces. A lot that was 98% at release can show new degradant peaks after improper storage or repeated freeze-thaw cycles. For handling, see semaglutide storage and stability and semaglutide reconstitution and handling. Stock concentration is simply mass divided by volume in mg/mL, which the calculator handles. For a lab that re-tests material over time, the practical approach is to retain an unopened reference vial and compare later chromatograms to the original.
Frequently asked questions
What does 98% purity on a semaglutide COA actually mean?
It means the main peak accounts for about 98% of the integrated HPLC signal at the stated wavelength and threshold. It does not measure net peptide content, counter-ions or water, and it says nothing about identity.
Why is mass spectrometry needed if HPLC already shows one clean peak?
HPLC shows how pure a species is, not what it is. Mass spectrometry confirms that the molecular mass matches semaglutide's formula, C187H291N45O59, including the fatty-acid side chain.
What mass should semaglutide show?
An average mass near 4,113.6 Da. In electrospray MS you will see several charge states that are deconvoluted to that neutral mass; compare the observed value with the theoretical value on the COA.
Can HPLC and MS miss a wrongly positioned side chain?
Intact mass cannot distinguish isomers with identical composition, though retention time may shift. Tandem MS or peptide mapping resolves it, but those are not routine on a standard COA.
Why do COAs mention TFA?
Trifluoroacetic acid is used in cleavage and HPLC purification, and some remains as a counter-ion. It can affect solubility and the peptide-to-solid ratio, so it is relevant to concentration accuracy.
Does a COA for one lot apply to the next?
No. Synthesis is batch-based, so a COA applies only to its lot number. Match the number on the document to your vial.
What does V8 list for semaglutide?
The product page lists a 10 mg size, ≥98% HPLC purity, the formula C187H291N45O59 and lyophilized powder supplied in a sealed glass vial.
How do I express a reconstituted semaglutide stock for lab work?
As mg/mL: vial mass divided by diluent volume. For instance, 10 mg in 2 mL gives 5 mg/mL. Use the calculator to check the arithmetic.
Research Use Only. For laboratory research use only; not for human consumption. Supplied strictly for laboratory research and development, not for human or veterinary use, and not for any diagnostic or clinical purpose. This article is research education, not usage guidance.
References
- Lau J, Bloch P, Schäffer L, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem. 2015;58(18):7370-7380.
- Semaglutide research overview
- Understanding HPLC purity
- HPLC vs. mass spectrometry
- How to read a COA
- Semaglutide product page